Results 171 to 180 of about 48,191 (295)
Immature reticulocyte fraction (IRF) and its correlation with hematological parameters: A comprehensive analysis across six age groups. [PDF]
Doğan Ö, Serdar MA.
europepmc +1 more source
ABSTRACT Dyskeratosis congenita (DC) is a rare telomere biology disorder characterized by mucocutaneous abnormalities and progressive bone marrow failure. We report a 10‐year‐old boy with a hemizygous DKC1 c.1058C > T (p.Ala353Val) variant who presented with unusually early mucocutaneous findings, including oral leukoplakia at 2 years of age, followed ...
Harun Kasapoğlu +4 more
wiley +1 more source
Three Faces of Self-Destruction: A Case Series of Warm, Cold, and Mixed Autoimmune Hemolytic Anemia. [PDF]
K H +6 more
europepmc +1 more source
High‐Altitude Hypoxemia in Adults With Sickle Cell Disease (SCD)
American Journal of Hematology, Volume 101, Issue 7, Page 1665-1669, July 2026.
Mofiyin A. Obadina +4 more
wiley +1 more source
Pediatric Wilson Disease in Sudan: A Rare Case, Sudan Conflict and Diagnostic Challenges
ABSTRACT Wilson disease is rarely reported among African children. Wilson disease is due to a mutation in ATP7B on an autosomal recessive pattern, which causes defective copper excretion and copper accumulation in tissues such as liver and brain.
Amjed Abdu Ali Mohammed +8 more
wiley +1 more source
Unmasking a High-Grade Malignant Neoplasm: A Rare Case of Small Bowel Melanoma. [PDF]
Vemulakonda LA, Reddi D, Liu Y.
europepmc +1 more source
ABSTRACT Thymomas are epithelial tumors of the anterior mediastinum and are frequently associated with paraneoplastic autoimmune disorders. Pure red cell aplasia (PRCA) is a rare but clinically significant complication, caused by immune‐mediated suppression of erythropoiesis.
Heba Amer +8 more
wiley +1 more source
Use of Human Intravenous Immunoglobulin Therapy in Two Dogs with Non-Neoplastic Bone Marrow Disorders Refractory to Immunosuppressive Therapy. [PDF]
Kim EJ, Han HJ.
europepmc +1 more source
Reticulocytes and their Humoral Regulation [PDF]
openaire +2 more sources
ABSTRACT Methotrexate (MTX) is a folate antagonist widely used as a disease‐modifying antirheumatic drug (DMARD) in rheumatoid arthritis (RA), as well as in several malignancies and autoimmune disorders. Although low‐dose MTX (5–20 mg/week) is generally considered safe, it has a narrow therapeutic index, and toxicity can occur even at therapeutic doses,
Fatemeh Afra +7 more
wiley +1 more source

